Publication | Closed Access
Monotherapy with tenofovir disoproxil fumarate for multiple drug‐resistant chronic hepatitis B: 3‐year trial
53
Citations
25
References
2017
Year
TDF monotherapy was efficacious and safe for up to 144 weeks, providing an increasing rate of virologic response in heavily pretreated patients with multidrug-resistant HBV. (Hepatology 2017;66:772-783).
| Year | Citations | |
|---|---|---|
Page 1
Page 1